Related Experiment Videos

[Coronary angioplasty in elderly patients. A therapeutic option]

Insights

Percutaneous transluminal coronary angioplasty (PTCA) is safe and effective for elderly patients with suitable coronary anatomy. This procedure offers significant symptomatic improvement in older individuals, comparable to younger patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Geriatric Medicine

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure for coronary artery disease.
  • Elderly patients represent a growing demographic undergoing cardiovascular interventions.
  • Limited data exists on the specific outcomes of PTCA in patients aged 65 and older.

Purpose of the Study:

  • To evaluate the safety and effectiveness of PTCA in elderly patients (≥65 years).
  • To compare outcomes of PTCA in elderly versus younger patients.
  • To assess long-term symptomatic improvement following successful PTCA in different age groups.

Main Methods:

  • Retrospective analysis of 304 consecutive PTCA cases performed between March 1986 and March 1988.
  • Inclusion of 61 patients aged 65 years or older.
  • Comparison of procedural success rates, complications, mortality, and late clinical follow-up between elderly and younger patient cohorts.

Main Results:

  • Elderly patients undergoing PTCA were more frequently female and had more calcific deposits (p < 0.0001).
  • Primary success rates were 82% in elderly patients versus 88% in younger patients.
  • Complications and mortality rates were statistically similar between the two age groups.
  • Late follow-up (mean 10 months) showed symptomatic improvement in 86% of successful elderly PTCA cases, compared to 80% in younger patients.

Conclusions:

  • PTCA is a safe and clinically effective revascularization strategy for elderly patients with suitable coronary anatomy.
  • Age is not a significant barrier to achieving positive outcomes with PTCA.
  • Elderly patients benefit from PTCA with substantial and sustained symptomatic relief.

Related Concept Videos